Clinical Trial Details
EORTC-30932
Back to Clinical Trials Database
Phase II study of 5-fluorouracil, Cisplatin and Interferon alpha in second line in advanced transitional cell cancer of the urothelial tract
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 21-Dec-1993 Date Step1 close: 05-Nov-1996 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 50 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
